ConcR Overview

  • Founded
  • 2018
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

ConcR General Information


Developer of a data-driven oncology treatment platform intended to improve cancer treatment through the prediction of patients response to treatments. The company's platform identifies optimal treatment for an individual, reduces treatment resistance, offers patient specific cancer progression, evidence based personalised treatment plan, enabling users to proactively adapt treatment before it becomes ineffective.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Software
Decision/Risk Analysis
Primary Office
  • 11 Milbrook
  • KT10 9EJ
  • England, United Kingdom
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ConcR Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view ConcR’s complete valuation and funding history, request access »

ConcR Executive Team (3)

Name Title Board Seat Contact Info
Matthew Griffiths Ph.D Co-Founder & Head, Technology
Eilish Middlehurst Co-Founder
Matthew Foster Co-Founder
To view ConcR’s complete executive team members history, request access »

ConcR Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Deep Science Ventures Accelerator/Incubator Minority 000 0000 000000 0
To view ConcR’s complete investors history, request access »